Trial Profile
Antiretroviral Regimens Containing Atazanavir/Ritonavir (ATZ/R) Unboosted Atazanavir (ATZ) or Darunavir/Ritonavir (DRV/R) in HIV/HCV-coinfected Patients: Evaluation of Safety, Effectiveness And Impact on Liver Fibrosis (MASTER Cohort)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Atazanavir/ritonavir; Darunavir/ritonavir
- Indications Hepatitis C; HIV infections
- Focus Adverse reactions; Therapeutic Use
- 02 Mar 2016 New trial record